Peptide ligand recognition by G protein-coupled receptors

被引:28
作者
Krumm, Brian E. [1 ]
Grisshammer, Reinhard [1 ]
机构
[1] NINDS, Membrane Prot Struct Funct Unit, NIH, Rockville, MD 20852 USA
基金
美国国家卫生研究院;
关键词
neurotensin receptor; peptide agonist; peptide GPCRs; GPCR structure; chemokine receptors; opioid receptors; protease activated receptors; RESOLUTION CRYSTAL-STRUCTURE; OPIOID RECEPTOR; NEUROTENSIN RECEPTOR; THROMBIN RECEPTOR; COMPLEX; AGONIST; CHEMOKINE; ADRENOCEPTOR; ANTAGONISTS; CXCR4;
D O I
10.3389/fphar.2015.00048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The past few years have seen spectacular progress in the structure determination of G protein-coupled receptors (GPCRs). We now have structural representatives from classes A, B, C, and F. Within the rhodopsin-like class A, most structures belong to the a group, whereas fewer GPCR structures are available from the beta, gamma, and groups, which include peptide GPCRs such as the receptors for neurotensin (beta group), opioids, chemokines (gamma group), and protease-activated receptors (F, group). Structural information on peptide GPCRs is restricted to complexes with non-peptidic drug-like antagonists with the exception of the chemokine receptor CXCR4 that has been crystallized in the presence of a cyclic peptide antagonist. Notably, the neurotensin receptor 1 is to date the only peptide GPCR whose structure has been solved in the presence of a peptide agonist. Although limited in number, the current peptide GPCR structures reveal great diversity in shape and electrostatic properties of the ligand binding pockets, features that play key roles in the discrimination of ligands. Here, we review these aspects of peptide GPCRs in view of possible models for peptide agonist binding.
引用
收藏
页数:6
相关论文
共 50 条
[21]   Therapeutic antibodies directed at G protein-coupled receptors [J].
Hutchings, Catherine J. ;
Koglin, Markus ;
Marshall, Fiona H. .
MABS, 2010, 2 (06) :594-606
[22]   The role of G protein-coupled receptors in lymphoid malignancies [J].
Nugent, Adrienne ;
Proia, Richard L. .
CELLULAR SIGNALLING, 2017, 39 :95-107
[23]   Ligand chain length drives activation of lipid G protein-coupled receptors [J].
Troupiotis-Tsailaki, Anastassia ;
Zachmann, Julian ;
Gonzalez-Gil, Ines ;
Gonzalez, Angel ;
Ortega-Gutierrez, Silvia ;
Lopez-Rodriguez, Maria L. ;
Pardo, Leonardo ;
Govaerts, Cedric .
SCIENTIFIC REPORTS, 2017, 7
[24]   Protein Design Strategies for the Structural-Functional Studies of G Protein-Coupled Receptors [J].
Dmitrieva, Daria A. ;
Kotova, Tatiana V. ;
Safronova, Nadezda A. ;
Sadova, Alexandra A. ;
Dashevskii, Dmitrii E. ;
Mishin, Alexey V. .
BIOCHEMISTRY-MOSCOW, 2023, 88 (SUPPL 1) :S192-S226
[25]   A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors [J].
Fidom, Kimberley ;
Isberg, Vignir ;
Hauser, Alexander S. ;
Mordalski, Stefan ;
Lehto, Thomas ;
Bojarski, Andrzej J. ;
Gloriam, David E. .
METHODS, 2015, 71 :104-112
[26]   Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state [J].
Huang, Jianyun ;
Chen, Shuai ;
Zhang, J. Jillian ;
Huang, Xin-Yun .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (04) :419-+
[27]   Functional characterisation of G protein-coupled receptors [J].
Uddin, Romez ;
Simms, John ;
Poyner, David .
METHODS, 2018, 147 :213-220
[28]   Hemorphins Targeting G Protein-Coupled Receptors [J].
Ayoub, Mohammed Akli ;
Vijayan, Ranjit .
PHARMACEUTICALS, 2021, 14 (03)
[29]   Role of G protein-coupled receptors in inflammation [J].
Lei Sun ;
Richard D Ye .
Acta Pharmacologica Sinica, 2012, 33 :342-350
[30]   Ubiquitination and Deubiquitination of G Protein-Coupled Receptors [J].
Jean-Charles, P. -Y. ;
Snyder, J. C. ;
Shenoy, S. K. .
UBIQUITINATION AND TRANSMEMBRANE SIGNALING, 2016, 141 :1-55